Article Versions Notes

Wang Q, Tian N, Zhang W, Lin Z, Shi F, Kong Y, Ren Y, Lyu J, Qin H, Liu H. Fatty Acid Synthase Mutations Predict Favorable Immune Checkpoint Inhibitor Outcome and Response in Melanoma and Non-Small Cell Lung Cancer Patients. Cancers. 2022; 14(22):5638. https://doi.org/10.3390/cancers14225638

Wang, Qinghua, Na Tian, Wenjing Zhang, Zhijuan Lin, Fuyan Shi, Yujia Kong, Yanfeng Ren, Juncheng Lyu, Hao Qin, and Hongqing Liu. 2022. "Fatty Acid Synthase Mutations Predict Favorable Immune Checkpoint Inhibitor Outcome and Response in Melanoma and Non-Small Cell Lung Cancer Patients" Cancers 14, no. 22: 5638. https://doi.org/10.3390/cancers14225638

Wang, Q., Tian, N., Zhang, W., Lin, Z., Shi, F., Kong, Y., Ren, Y., Lyu, J., Qin, H., & Liu, H. (2022). Fatty Acid Synthase Mutations Predict Favorable Immune Checkpoint Inhibitor Outcome and Response in Melanoma and Non-Small Cell Lung Cancer Patients. Cancers, 14(22), 5638. https://doi.org/10.3390/cancers14225638